Translatable efficacy & safety testing of CAR T therapies
Learn about monoclonal antibody-based human immune modulation in enhancing therapeutic outcomes
Source: selectscience.net
Page 7 - Ar T News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ar T. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ar T Today - Breaking & Trending Today
Translatable efficacy & safety testing of CAR T therapies
Learn about monoclonal antibody-based human immune modulation in enhancing therapeutic outcomes
Source: selectscience.net
Toronto Stocks Edge Lower; Argonaut Gold Slides on C$80M Fundraiser
By Adriano Marchese Toronto-listed shares were mildly lower Monday at midday. Investors are awaiting Wednesday's Bank of Canada decision on interest rates,...
Source: marketwatch.com
FDA Investigates Secondary Cancers From CAR T-Cell Therapies
The FDA has determined that the risk for lymphoma and other T-cell cancers may apply to approved BCMA- and CD-19–directed CAR T-cell immunotherapies.
Source: medscape.com
FDA Probes New Cases of Cancer That May Stem From Cancer Cell Therapies
CAR T-therapies for cancer are now under tighter FDA scrutiny as the agency opens an inquiry regarding reports that some patients who received these cell therapies went on to develop new cases of cancer. The FDA said benefits of these therapies still outweigh their risks, but it is evaluating the need for regulatory action.
Source: medcitynews.com